Schonfeld Strategic Advisors LLC
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 1665241
NEW YORK, NY
Position in ARWR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$748,832
+$121,707 QoQ
Shares Held
9,187
-8.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#263
of 497 holders
Holding Since
Sep 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARWR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Schonfeld Strategic Advisors LLC holds $420,669,608 across 133 Biotechnology names. ARWR ranks #80 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INBX |
Inhibrx Biosciences, Inc.
|
697,586 | $66,096,273 | |
| 2 | AGIO |
Agios Pharmaceuticals, Inc.
|
520,083 | $19,300,280 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
77,272 | $18,620,233 | |
| 4 | VRDN |
Viridian Therapeutics, Inc.\DE
|
793,508 | $14,576,741 | |
| 5 | MBX |
MBX Biosciences, Inc.
|
248,670 | $13,726,584 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
227,330 | $13,721,638 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
147,425 | $12,025,457 | |
| 8 | INSM |
INSMED Inc
|
104,378 | $11,128,782 |
All Filings in ARWR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $748,832 | 9,187 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $627,125 | 10,002 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $1,334,770 | 20,105 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $18,759,662 | 543,916 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $7,616,469 | 482,055 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $670,378 | 52,620 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $11,885,623 | 632,214 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $7,509,497 | 387,687 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,666,451 | 410,406 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $11,891,393 | 415,783 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $14,084,476 | 460,277 | Shares | Sole | 2024-02-14 | |
| 2023-06-30 | $800,353 | 22,444 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $701,688 | 17,300 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,501,197 | 45,422 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $364,810 | 10,361 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $809,424 | 17,600 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $1,245,578 | 18,787 | Shares | Sole | 2022-02-14 | |
| 2021-03-31 | $252,044 | 3,801 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,175,580 | 15,321 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,345,668 | 31,251 | Shares | Sole | 2020-11-19 | |
| No filing history on record for this holder in this stock. | ||||||